2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ensol Bioscience: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects C1K 150mg, C1K 300mg, Placebo with the same volume of C1K 300mg - Healthy | Phase 1 | Completed | Ensol Bioscience | 36 | 2023-01-02 | 2024-04-04 |
| E1K Intra Articular(IA) Treatment for Knee Osteoarthritis E1K 1,200 ㎍/joint, E1K 2,400 ㎍/joint, placebo - Osteoarthrosis | Phase 2 | Completed | Ensol Bioscience | 120 | 2022-06-13 | 2024-04-04 |
Osteoarthritis (1)
South Korea (2)